Frazier Life Sciences XI, L.P. — Form D
Frazier Life Sciences XI, L.P. of MENLO PARK, CA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-03-18. The offering totals $960.0M, of which $960.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-03-18
- Form: D
- Accession: 0001911592-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $960.0M
- Amount sold: $960.0M
- Investors: 98
- Date of first sale: 2022-03-15
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-438073
Issuer
- Name: Frazier Life Sciences XI, L.P.
- CIK: 0001911592
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 70 WILLOW ROAD, SUITE 200, MENLO PARK, CA, 94025
- Phone: (206) 621-7200
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Daniel J Estes | Executive Officer | Palo Alto, CA |
| Patrick J Heron | Executive Officer | Menlo Park, CA |
| James N Topper | Executive Officer | Cranbury, NJ |
More